Oakworth Capital’s Fresenius Medical Care FMS Stock Holding History

Oakworth Capital’s Portfolio FMS Stock Details FMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-3,000	Closed	-$126K	–	508
2015 Q1	$126K	Hold	3,000	–	–	0.06%	144
2014 Q4	$111K	Buy	+3,000	New	+$108K	0.06%	139

Other funds holding FMS

Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

MAMU

Marathon Asset Management (UK) London, United Kingdom $2.61B AUM 27.14% 1-Year Est. Return

TIM

Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return

VAM

Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

JFL

Jarislowsky, Fraser Ltd Montreal, Quebec, Canada $18.2B AUM 22.04% 1-Year Est. Return

MNA

Manning & Napier Advisors Fairport, New York $7.09B AUM 17.35% 1-Year Est. Return

Oakworth Capital's FMS Position: Q2 2015 in Review

Oakworth Capital sold out of Fresenius Medical Care (FMS) in Q2 2015, closing a stake of 3,000 shares — an estimated $126K sold.

Oakworth Capital first reported a position in FMS in Q4 2014 and held it in 2 quarters. The position peaked at $126K in Q1 2015. 144 funds tracked by Wall St. Rank hold FMS as of Q2 2015.

Oakworth Capital reported no remaining Fresenius Medical Care position as of Q2 2015 after selling out during the quarter.
Oakworth Capital sold 3,000 Fresenius Medical Care shares in Q2 2015, an estimated $126K.
Oakworth Capital first reported a position in Fresenius Medical Care in Q4 2014 and held it in 2 quarters.
Oakworth Capital's Fresenius Medical Care position peaked at $126K in Q1 2015.
144 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q2 2015.

Based on Oakworth Capital's 13F filing for Q2 2015, filed 14 Jul 2015.